NFKB1 and hepatocellular carcinoma: Few in vitro studies have shown the effects of inflammation and cholesterol metabolism; they studied the effect of LPS treatment in hepatocellular carcinoma HCC cells and found that the treatment induced an increase in intracellular cholesterol accumulation by the NF-κB pathway [51].